No Picture
Los Angeles Biotech News

It is ‘kind of a proven technology’: Hep B vaccine maker joins global hunt for coronavirus vaccine

Using lab-grown proteins that are engineered to mimic the architecture of viruses to induce an immune response, VBI Vaccines is joining the hunt for a coronavirus vaccine ? harnessing technology that has initially been proved safe in early trials as a … […]

No Picture
Los Angeles Biotech News

Jim Robinson takes over the reins at Urovant; Carlos Campoy moves to CytomX

Jim Robinson
? After nearly a year as president and COO at Paragon Biosciences, Jim Robinson has jumped to Urovant Sciences, where he will be president and CEO of the urology-focused biotech, succeeding founding CEO Keith Katkin. Robinson will continue… […]

No Picture
Los Angeles Biotech News

CG Oncology Announces License and Commercialization Agreement with Kissei Pharmaceutical Co., Ltd. for CG0070 in Japan and Other Asian Countries

IRVINE, Calif.–(BUSINESS WIRE)–CG Oncology, Inc. has announced today an exclusive license, development and commercialization agreement with Kissei Pharmaceutical Co., Ltd. ("Kissei") for its oncolytic immunotherapy drug CG0070 for Japan, So… […]

No Picture
Los Angeles Biotech News

Horizon Therapeutics plc Donates $1.5 Million to COVID-19 Response Efforts in Illinois and Other Impacted U.S. and Global Communities

LAKE FOREST, Ill.–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it, in partnership with Illinois Governor JB Pritzker, has provided $500,000 to the Illinois COVID-19 Response Fund and $500,000 to the Illinois Biotechnol… […]

No Picture
Los Angeles Biotech News

EMA offers methodological considerations for trials during Covid-19 pandemic

The European Medicines Agency (EMA) on Wednesday released for consultation a new draft guideline on points that clinical trial sponsors should consider on the implications of the coronavirus disease (Covid-19) on methodological aspects of ongoing trial… […]

No Picture
Los Angeles Biotech News

XPRIZE Responds to COVID-19 by Uniting a Global Alliance of Innovators to Find Unconventional Solutions to Pandemic Threats

LOS ANGELES–(BUSINESS WIRE)–XPRIZE, the world?s leader in designing and operating incentive competitions to solve humanity?s grand challenges, reveals the XPRIZE Pandemic Alliance, a global coalition that combines the power of collaboration, competit… […]

No Picture
Los Angeles Biotech News

Xencor and Vir Biotechnology Enter License Agreement for Use of Xtend? XmAb? Antibody Technology in Investigational Antibodies to Treat COVID-19

MONROVIA, Calif.–(BUSINESS WIRE)–Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune disease, today announced it has entered into a technology l… […]

No Picture
Los Angeles Biotech News

Impact of 2020 Crisis on Global Medical Devices & Diagnostics Market – New Forecasts from HRI & LSI

HUNTINGTON BEACH, Calif.–(BUSINESS WIRE)– #lsintelligence–Life Science Intelligence (LSI) and Health Research International (HRI) have been tracking and publishing market data on the global medical devices & diagnostics market for over three dec… […]

No Picture
Los Angeles Biotech News

Emmaus Life Sciences Provides Update in Response to the Coronavirus (COVID-19) Pandemic

TORRANCE, Calif., March 24, 2020 (GLOBE NEWSWIRE) — Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease (SCD) treatment, announced today several steps it has taken in response to the Coronavirus (COVID-19) pandemic. Within the … […]